$UFPT

BAILLY R JEFFREY sold $4.1M of UFPT (indirect holdings)

BAILLY R JEFFREY (Executive Chairman) sold 13,011 indirectly-held shares of UFP TECHNOLOGIES INC (UFPT) at an average of $316.13 ($315.53–$317.27, $4.11M total) across 3 trades on 2026-08-10.

Original reporting
SEC EDGAR · BAILLY R JEFFREY
Published Aug 11, 2026, 7:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 7:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$UFPT
Neutral
medium confidence
Mentioned
$UFPT
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UFPTNeutralLow
01

Why it matters

The only new information is the disclosed open-market sale size, timing (Aug 10), price range, and that holdings after the transaction are 0 shares, with no pre-arranged 10b5-1 plan stated.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone does not change the company’s earnings or guidance outlook.

03

What to watch

The article does not clarify whether the sale was part of broader compensation/withholding mechanics, nor does it provide context on prior insider activity or total remaining holdings before the sale.

Relevance 6/10Novelty 3/10Timing: filed Aug 11 after Aug 10 sale trades

Background

This is an SEC Form 4 insider transaction disclosure for UFP Technologies, reported by Executive Chairman Bailly R. Jeffrey.

Company-level read

Ticker impact

$UFPTNeutralMedium confidence
Context

UFP Technologies disclosed an insider Form 4 showing Executive Chairman Bailly sold about $4.11M of UFPT shares via an open-market sale.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than based on new company performance data.

Evidence & confidence

Form 4 insider sales are common and the article provides no accompanying earnings, guidance, or operational change. The absence of a 10b5-1 plan can raise scrutiny, but the text does not link the sale to any specific event or outlook change.

Market effects

No clear sector read-through because the disclosure is company-specific and lacks operational or regulatory details.

None indicated.

None indicated.

Counterpoint

The sale could be purely liquidity or diversification related, especially since the filing shows multiple small trades and no stated company-specific reason.

Key entities

  • UFP Technologies Inc

    Subject of the Form 4 insider sale disclosure.

  • Bailly R. Jeffrey

    Executive Chairman and reporter of the Form 4 sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UFPTMedAI 8/10

UFP Technologies (UFPT) Q2 2026 Earnings Call Transcript

UFP Technologies (UFPT) reported Q2 2026 net sales of $174 million, up 15.1%, with organic sales growth of 12.4%. Adjusted EPS rose 16.8% to $2.92 and gross margin increased to 29.3%. Adjusted EBITDA was $36.4 million. Management cited MedTech strength, low leverage under 1x, and an acquisition pipeline of 5 to 10 opportunities.

$UFPTMedAI 8/10

Why UFP Technologies Stock Is Skyrocketing Today

UFP Technologies (NASDAQ: UFPT) shares rose about 24% by 2 p.m. ET after the company reported strong Q2 results. UFP said sales grew 15%, adjusted EPS rose 17%, and revenue increased 15% to its five largest customers. The company also reported 12% organic growth and 20% growth in its core medtech unit, and is monitoring tuck-in acquisitions.

$UFPTMedAI 8/10

Why Is UFP Technologies (UFPT) Stock Soaring Today

UFP Technologies (UFPT) shares rose 18.5% after the company reported Q2 2026 results that beat Wall Street. Revenue increased 15.1% to $174 million, adjusted EPS was $2.92 versus $2.56 expected, and adjusted EBITDA was $36.39 million, 11.5% above forecasts, according to the company.